These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 5117309)

  • 1. Addition of drugs to intravenous fluids.
    Engel G
    Med J Aust; 1971 Nov; 2(19):962-6. PubMed ID: 5117309
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemical incompatibility of parenteral drug admixtures.
    McCarthy TJ
    S Afr Med J; 1974 Sep; 48(46):1951-3. PubMed ID: 4421027
    [No Abstract]   [Full Text] [Related]  

  • 3. [Physicochemical incompatibilities of injectable drugs].
    Hoffman M; Hazebroucq G
    Sem Hop; 1983 Feb; 59(8):541-7. PubMed ID: 6302899
    [No Abstract]   [Full Text] [Related]  

  • 4. Fatal drug reactions among medical inpatients.
    Shapiro S; Slone D; Lewis GP; Jick H
    JAMA; 1971 Apr; 216(3):467-72. PubMed ID: 5107928
    [No Abstract]   [Full Text] [Related]  

  • 5. Continuous versus intermittent intravenous antibiotics.
    Med Lett Drugs Ther; 1968 Jul; 10(15):57-8. PubMed ID: 5667663
    [No Abstract]   [Full Text] [Related]  

  • 6. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets.
    Allen LV; Levinson RS; Phisutsinthop D
    Am J Hosp Pharm; 1977 Sep; 34(9):939-43. PubMed ID: 20779
    [No Abstract]   [Full Text] [Related]  

  • 7. Calcium and phosphate compatibility: revisited again.
    Newton DW; Driscoll DF
    Am J Health Syst Pharm; 2008 Jan; 65(1):73-80. PubMed ID: 18159044
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the stability and compatibility of drugs in infusion fluids. VI. Factors affecting the stability of ampicillin.
    Stjernström G; Olson OT; Nyqvist H; Lundgren P
    Acta Pharm Suec; 1978; 15(1):33-50. PubMed ID: 25558
    [No Abstract]   [Full Text] [Related]  

  • 9. [Incompatibility and other problems in adding drugs to intravenous fluids].
    Hvidberg E; Bols T; Jacobsen N
    Ugeskr Laeger; 1973 Jun; 135(24):1221-9. PubMed ID: 4754570
    [No Abstract]   [Full Text] [Related]  

  • 10. Compatibility of selected critical care drugs during simulated Y-site administration.
    Yamashita SK; Walker SE; Choudhury T; Iazzetta J
    Am J Health Syst Pharm; 1996 May; 53(9):1048-51. PubMed ID: 8744469
    [No Abstract]   [Full Text] [Related]  

  • 11. Cimetidine hydrochloride compatibility. II: room temperature stability in intravenous infusion fluids.
    Yuhas EM; Lofton FT; Mayron D; Baldinus JG; rosenberg HA
    Am J Hosp Pharm; 1981 Jun; 38(6):879-81. PubMed ID: 7246564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parenteral incompatibilities--past, present and future.
    Parker EA; Boomer RJ; Bell SC
    Bull Parenter Drug Assoc; 1967; 21(6):197-207. PubMed ID: 6078886
    [No Abstract]   [Full Text] [Related]  

  • 13. Infusion thrombophlebitis.
    Lewis GB; Hecker JF
    Br J Anaesth; 1985 Feb; 57(2):220-33. PubMed ID: 3882110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of parenteral solutions of tobramycin sulfate.
    Bergstrom RF; Fites AL; Lamb JW
    Am J Hosp Pharm; 1975 Sep; 32(9):887-8. PubMed ID: 242216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Problems of use and preparation of infusion mixtures. 3. Current opinion of the utilization of infusion mixtures in therapy].
    Samková M; Malý J
    Cesk Farm; 1971 Sep; 20(7):269-75. PubMed ID: 4999860
    [No Abstract]   [Full Text] [Related]  

  • 16. DEXTRAN IN THE TREATMENT OF THROMBOPHLEBITIS.
    COX EF; FLOTTE CT; BUXTON RW
    Surgery; 1965 Feb; 57():225-9. PubMed ID: 14263793
    [No Abstract]   [Full Text] [Related]  

  • 17. Physical compatibility of metoprolol tartrate injection with selected cardiovascular agents.
    Newland AM; Mauro VF; Alexander KS
    Am J Health Syst Pharm; 2009 Jun; 66(11):986-7. PubMed ID: 19451606
    [No Abstract]   [Full Text] [Related]  

  • 18. Visual compatibility of ganciclovir sodium and total parenteral nutrient solution during simulated Y-site injection.
    Outman WR; Mitrano FP; Baptista RJ
    Am J Hosp Pharm; 1991 Jul; 48(7):1538-9. PubMed ID: 1909095
    [No Abstract]   [Full Text] [Related]  

  • 19. Precipitation of verapamil in an intravenous line.
    Tucker R; Gentile JF
    Ann Intern Med; 1984 Dec; 101(6):880. PubMed ID: 6497208
    [No Abstract]   [Full Text] [Related]  

  • 20. Visual compatibility of haloperidol lactate with 0.9% sodium chloride injection or injectable critical-care drugs during simulated Y-site injection.
    Outman WR; Monolakis J
    Am J Hosp Pharm; 1991 Jul; 48(7):1539-41. PubMed ID: 1882889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.